Importantly, MPO-DNA levels were higher in MPN patients with previous thrombosis, especially with splenic thrombosis, positioning itself as a biomarker of thrombosis in patients with MPN [76]. The gene discussed is MPO; the disease is myeloproliferative neoplasm.